Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations | ALVO Stock NewsStockTitan·1 day ago, 07:30 PMALVO+4.85%TEVA-1.07%
Alvotech executives to speak at Morgan Stanley Global Healthcare Conference fireside chatPUBT·Aug 27 at 07:01 AMALVO+4.85%MS-0.68%
Alvotech (NASDAQ:ALVO) Shares Gap Up - What's Next?Market Beat·Aug 24 at 10:00 AMALVO+4.85%GS-A-0.31%
Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On Mondaybenzinga_article·Aug 24 at 09:22 AMALVO+4.85%RUMBW-0.46%
Why Alvotech (ALVO) Is Up 9.2% After $150 Million Lotus Biosimilar Deal And 2026 UpdateSimplywall·Aug 22 at 02:39 AMALVO+4.85%
Weekly Recap | Alvotech SA +9.25%, full-year guidance reaffirmedWeekly Review·Aug 22 at 01:55 AMALVO+4.85%
Alvotech (NASDAQ:ALVO) Sees Strong Trading Volume - What's Next?Market Beat·Aug 21 at 01:00 PMALVO+4.85%GS-0.78%
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets | ALVO Stock NewsStockTitan·Aug 21 at 12:00 AMALVO+4.85%
Alvotech (ALVO) Stock Rises On Guidance Resolve Despite Lingering Loss RiskSimplywall·Aug 20 at 06:40 PMALVO+4.85%
